Article info
PDFClinical and epidemiological research
Extended report
Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry
- Correspondence to Mrs Bente Glintborg, Gentofte University Hospital, Niels Andersensvej 65, 2900, Hellerup, Denmark; glintborg{at}dadlnet.dk
Citation
Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry
Publication history
- Accepted April 20, 2010
- First published May 28, 2010.
Online issue publication
November 02, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions